ID: ALA45980

Max Phase: Preclinical

Molecular Formula: C12H18O7

Molecular Weight: 274.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC(=O)OCC(O)C1OC(=O)C(OC)=C1OC

Standard InChI:  InChI=1S/C12H18O7/c1-4-5-8(14)18-6-7(13)9-10(16-2)11(17-3)12(15)19-9/h7,9,13H,4-6H2,1-3H3

Standard InChI Key:  AXWPYBDEKYPXRD-UHFFFAOYSA-N

Associated Targets(non-human)

Alpha-amylase 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 274.27Molecular Weight (Monoisotopic): 274.1053AlogP: 0.12#Rotatable Bonds: 7
Polar Surface Area: 91.29Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.49CX Basic pKa: CX LogP: -0.10CX LogD: -0.10
Aromatic Rings: 0Heavy Atoms: 19QED Weighted: 0.66Np Likeness Score: 1.45

References

1. Abell AD, Ratcliffe MJ, Gerrard J..  (1998)  Ascorbic acid-based inhibitors of alpha-amylases.,  (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4]

Source